4 unchanged sentences
We do not expect any such current legal proceedings to have a material adverse impact on our business or financial condition.
−Removed: Additional information regarding our current legal proceedings can be found in Note 16 of notes to our consolidated financial statements included in Item 8 of this report.
Mine Safety Disclosure s
32 unchanged sentences
from the University of Nottingham.
−Removed: Flannelly , age 63, has served as Executive Vice President and General Manager, NA since June 2015 and joined Incyte as Executive Vice President, Business Development and Strategic Planning in August 2014.
+Added: Flannelly , age 64, has served as Executive Vice President and General Manager, North America since June 2015 and joined Incyte as Executive Vice President, Business Development and Strategic Planning in August 2014.
Prior to joining Incyte, he served as Chief Executive Officer of OSS Healthcare Inc., a biotechnology start-up company, from August 2013 to July 2014.
−Removed: He served as Vice President, Global Product Strategy and Commercial Planning of Nektar Therapeutics, a biopharmaceutical company, from April 2011 until April 2013, and as Senior Vice President, Commercial, of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, from August 2008 until January 2011.
+Added: He served as Vice President, Global Product Strategy and Commercial Planning of Nektar
+Added: Therapeutics, a biopharmaceutical company, from April 2011 until April 2013, and as Senior Vice President, Commercial, of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, from August 2008 until January 2011.
Prior thereto, Dr.
29 unchanged sentences
Christiana Stamoulis, age 51, joined Incyte in February 2019 as Executive Vice President and Chief Financial Officer.
−Removed: Prior to joining Incyte, she served as President from February 2018 until January 2019 and Chief Financial Officer
−Removed: from January 2015 to January 2019 of Unum Therapeutics Inc., a biopharmaceutical company.
+Added: Prior to joining Incyte, she served as President from February 2018 until January 2019 and Chief Financial Officer from January 2015 to January 2019 of Unum Therapeutics Inc., a biopharmaceutical company.
From January 2014 until she joined Unum, Ms.
23 unchanged sentences
in Psychology and Industrial Relations from Rockhurst University.
−Removed: Wenqing Yao , age 58, has served as Executive Vice President, Head of Discovery Chemistry since October 2014.
−Removed: Yao joined Incyte as Director, Chemistry in February 2002 and held roles of increasing responsibility at Incyte.
−Removed: Prior to joining Incyte, Dr.
−Removed: Yao held scientific research positions with DuPont Pharmaceuticals and Bristol-Myers Squibb Company from 1996 to 2002.
−Removed: Yao received his B.S.
−Removed: in chemistry from Xuzhou Normal University, his M.S.
−Removed: in organic chemistry from NanKai University and his Ph.D.
−Removed: in organic/medicinal chemistry from the University of Pennsylvania.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.